Turnaround & Crisis Management
Biopharma Turnaround and Crisis Management
Not every biopharma company is in trouble when it needs a turnaround advisor. Sometimes the company is performing adequately but is not performing to its potential. Sometimes a clinical setback, a leadership transition, a regulatory crisis, or a capital market dislocation has created a situation that requires experienced, decisive external support to navigate.
At Katogen, turnaround and crisis management is not a theoretical service. We have personally led organizations through exactly these situations — stabilizing companies in crisis, rebuilding leadership teams, restructuring balance sheets, and reorienting strategies that had stopped working. We bring that direct experience to every engagement.
What We Do
Situation Assessment The first step in any turnaround is an honest, rapid assessment of the situation — the financial position, the operational reality, the competitive landscape, and the strategic options available. We do not soften the diagnosis. We give leadership teams and boards the clear picture they need to make the right decisions.
Strategic Reorientation Sometimes a turnaround requires a fundamental change in strategic direction — a new target indication, a pivot in business model, a portfolio rationalization, or a shift in commercial strategy. We help leadership teams make those decisions with clarity and conviction.
Leadership and Organizational Stabilization Crisis situations destabilize organizations. Key talent leaves. Teams lose confidence. Execution slows at exactly the moment speed is most critical. We help companies stabilize their leadership and organizational dynamics — retaining the people who matter most and rebuilding the execution capability needed to move forward.
Balance Sheet and Capital Strategy Many biopharma crises have a capital dimension — a runway that is shorter than it appears, a capital structure that is not supportable, or a financing need that the current investor base cannot or will not meet. We help companies restructure their balance sheet, identify new capital sources, and build the financial narrative needed to attract capital in difficult circumstances.
Stakeholder Management Board management, investor communication, regulatory engagement, and partner relations all require careful, coordinated management in a crisis situation. We help leadership teams build and execute stakeholder communication strategies that maintain confidence and preserve optionality.
Who This Is For
Boards, CEOs, and executive teams at biopharma companies navigating a significant operational, financial, regulatory, or strategic change — or companies that are performing adequately but recognize that decisive intervention is needed to reach their potential.
Why Katogen
We have been in the room when the hard decisions had to be made. We have led organizations through clinical failures, capital crises, leadership transitions, and strategic pivots. We bring that experience — and the equanimity that comes with it — to every turnaround engagement.